Metabolic risk in depression and treatment with selective serotonin reuptake inhibitors: are the metabolic syndrome and an increase in cardiovascular risk unavoidable?

Autor:	Manuel Nava, Victor Lameda, Mervin Chávez-Castillo, Joselyn Rojas-Quintero, Jorge Fuenmayor, Valmore Bermúdez, Manuel Velasco, Ángel Ortega
Rok vydání:	2018
Předmět:	business.industry Metabolic risk medicine Type 2 Diabetes Mellitus Metabolic syndrome Serotonin reuptake Cardiology and Cardiovascular Medicine medicine.disease Bioinformatics business Depression (differential diagnoses)
Zdroj:	Vessel Plus. 2:6
ISSN:	2574-1209
DOI:	10.20517/2574-1209.2018.02
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::03571c80d54c80bb822492e24fa280bd https://doi.org/10.20517/2574-1209.2018.02 Zobrazit plný text záznamu